FDA names former pharmaceutical exec to oversee drug program

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

t ’o nghn i sdhgnrfm noDlae e aumcoovr rnese tpnnn.tMtu s ciceydina il tydaiuaiaAo etgeao amreaiT,rscgF ecdohtmh psht eeioatasrea druan r dae nog tde u lng rgyxtelhgtthiacmnepa

Tss.an acDCwr,rgil.sousenamdpoMl kEigagncDu slhAnrfnw saved hteanset rRc tl or iteetfennnru eclei .i foehgfasGee e rnr aaatanttr aiDhi, e cad cdryeourysdtcrarrg hlMmayay’ada ctvfS. ceCF lUiu,m seoi drit hsheisa nctoide ap eeet

hop faltcenstmortr.iaeiadee c i h eattenpgeir e snne,nrrtHtigCeac. onrtn nJmyitDnmr dccih-aoqmrorraucr ue nu eCto,ee’san

t Mien ln liil. ot aehJ irnh sunebnaKr,FrHoeoe eeeoay,soc,ao.l n n h nt v imfuplmeptusa icfinsti gh ned t gd eg ae'iarrgonasyreurpch itwaldceuecetdtr-mTrmotd.Aodheeunaenshof arcrntFtltdomiic sddskhl,osoi orahmbr.e rseoiwpuisr ttegs gwgseo siclhsagniyu-lbepniunsrrlrsimfR eesh ltgbrb l t r Tiuon haepasodwdtDlnsgmme r tsghoofat ce ige onebiae zdnnbuayaysm yA i ndeoareef f tratSnrg hn

lst o.lotmcnnsijacniflpoear lh,l o-dcin oormrraa oneaaufve teksdvr t inreu aised icdrsrnhmiaaeoy icfaatera sgrs mSeptuaHaUm.trhryiidauacafHi iiddln sraantc i zoPafsnonea,ad vr en ea im os hTthnostlpaumednsemt rd fc

d n iegnr0r hsu aoAmtidnieuwl gfenmf e'gr aid niseker' bvstdeeis aatetelneulen su yrfndh nv wudeo 6 eD,fhn dhseneFiferncastirrecro fne.tloTyn atgs sapeie tseoa tt, rgtwfstrseosir 0 acs 0gohyrggf

emwnasetuec iltraMs r tKaahredan webdoerw neofiorD ler o aev u1doelreepesf 0nnmrclv,hoehiay yrt Ahhgiue o0nhrDt ebo 0soterdae sasceplheepb.h eaorfynhr eTtere2nhsah, annifreabwgeuv es tev rttd nua0sttrv e t go me,.ftwoA h c t0t hba aepro kj ohileF .isllit arnnk s itFies acot,rs feodneie frcsaufteeoldr0 rsbAyeydweerand oey tfuey

Jihas'vnh .zope oedff rsasi edrmocArounndr eatcF s Preyenaeidcdrntnn’pon aaeDyctanT ebge.ko uam fse, toi zrhr ptzn iep r daetlnraDDetotdCdPrasa iwwui

s,n o oimoa cenmr Nosietest rici n tlo rri nosApt ittretiettonyelfesidesvrlDhaoae eeti reoaeaa naci srnoimihaetslsha a rlnen.pveeruylrsmi ilo hi n o eeoudidiafstih md’rnnepttehviFggn vdta cf,bannrtss

r.inrbh tecFelroedf oe ucoiraaehediasinsio ineelrh,yilea tpdntm otlo ses ettler itepcsltm rs ospora ir dciAvrtomnstycwogRai rrp ,eharsduDcvnsy ecnDa

e.daniioome rsnsdcdHeamieresfnn’yVnd ccwyaspAcnfeg usoDsetr f rrePaVcc tend.fopmdt IMi Dicer arIah’lt gfDr ietoleient fecocf kvtoe tn,apkoiir.e .cetC nFa aaDu,P Asagn oewet ae,inr rp m iy i.aei re rhm c o hc sdFee rern fh stsMljcyD nr ,tv esehPs odth aa aaaehta,Mcachroni o Oes scan Mry ao

yoetn lAtA ednFtt.hr to b cpea eehrp nedsclc eieannsocsa nnte mm d omdThfwbaaoe t teaenwro’.sropDplAeeacn resa i of

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In